Massive study aims to decode immune secrets of gut diseases and transplant rejection

NCT ID NCT03369353

First seen Mar 18, 2026 · Last updated May 15, 2026 · Updated 3 times

Summary

This study is collecting blood and tissue samples from 1,000 people with inflammatory bowel disease (IBD), graft-versus-host disease (GVHD), or functional gut disorders, as well as those receiving cell therapies like CAR-T. Researchers will analyze the immune system in detail to find the root causes of these conditions. The goal is to improve diagnosis and create personalized treatments, but this study does not test any new drug or therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRAFT-VS-HOST DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Boston Children's Hospital

    Boston, Massachusetts, 02115, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, 02215, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Seattle Children's Hospital

    Seattle, Washington, 98105, United States

Conditions

Explore the condition pages connected to this study.